Propofol/Dexmedetomidine Versus Desflurane Effects on Post Hepatectomy Hepatocellular Injury
- Conditions
- Hepatectomy
- Interventions
- Registration Number
- NCT05246371
- Lead Sponsor
- Ain Shams University
- Brief Summary
This study will compare the effects of propofol/dexmedetomidine versus desflurane for maintenance of general anesthesia on hepatocellular injury in patients undergoing partial hepatectomy.
- Detailed Description
Postoperative impairment of liver function is common after hepatectomy. It may be caused by surgical trauma, loss of hepatic mass, stress response, hepatic oxygen deprivation, infection and drug toxicity.
Anesthetic agents used in general anesthesia for liver surgery have a big effect on hepatic blood flow, oxygen delivery and liver function This study will compare the effects of propofol/dexmedetomidine versus desflurane for maintenance of general anesthesia on hepatocellular injury in patients undergoing partial hepatectomy.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 30
- Patients American Society of Anesthesiologists physical status (ASA) I to II.
- Patients Child Pugh classification A to B.
- Both sexes.
- Aged between 18 years and 70 years
- Scheduled for more than 1 segment hepatectomy.
- Patients with Child Pugh classification C.
- Patients younger than18 years old or older than 70 years old
- Patients performed additional ablation therapies (cryosurgery or radiofrequency ablation).
- Prior liver resection for donation.
- Scheduled resection not requiring inflow occlusion (Pringle's maneuver).
- Hypersensitivity to any of the used drugs.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description desflurane Desflurane Patients will receive maintenance of general anesthesia by desflurane. propofol and dexmedetomidine Propofol, dexmedetomidine Patients will receive maintenance of general anesthesia by TIVA using combination of propofol and dexmedetomidine
- Primary Outcome Measures
Name Time Method bilirubin 1 week bilirubin
albumin 1 week albumin
aspartate aminotransferase (AST) 1 week aspartate aminotransferase (AST)
alanine aminotransferase (ALT) 1 week alanine aminotransferase (ALT)
prothrombin time 1 week prothrombin time
INR 1 week INR
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Ain Shams University
🇪🇬Cairo, Egypt